[Epidemiology and diagnosis of breast cancer].Agnieszka Budny, Franciszek Burdan, Elżbieta Starosławska et al.|PubMed|2019Cited by 30
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Christos Papadimitriou, Tomasz Sarosiek et al.|Breast Cancer Research and Treatment|2014Cited by 27
Spinal Perineural Cysts among European PatientsPiotr Kozłowski, Franciszek Burdan, Elżbieta Starosławska et al.|Journal of Neurological Surgery Part A Central European Neurosurgery|2021Cited by 13
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Christos Papadimitriou, Tomasz Sarosiek et al.|The Breast|2015Cited by 11
Abstract P5-18-21: A Phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for ErbB2-overexpressing metastatic breast cancer (MBC)W Janni, C Papadimitriou, Tomasz Sarosiek et al.|Cancer Research|2012Cited by 2